The TCS London Marathon has named Pancreatic Cancer UK as its official charity for 2025.

The charity aims to raise £2m through the partnership as it takes over from Samaritans, the event’s partner this year.

“The 2025 TCS London Marathon will be one of the most important days for pancreatic cancer ever and we are so, so proud to be the official charity of the year,” said Pancreatic Cancer UK’s chief executive Dianna Jupp.

“For 50 years, research into this devastating disease has been underfunded and left behind, leaving families with only hope to hold on to.”

Previous official charity partners have included the British Heart Foundation, which raised £2.3m in 2022.

London Marathon event director Hugh Brasher said that the charity’s cause is close to his family after his father, the event’s co-founder Chris Brasher, died from the disease six months after he was diagnosed “so I know well the devastating impact of this disease”.

“We wish the team at Pancreatic Cancer UK all the very best in their efforts and look forward to working with them in the year ahead,” he added.

To coincide with the announcement the charity has launched a new logo, which it hopes to feature on the kits of 800 runners it aims to recruit for the event.

“The charity is also changing the way it communicates, with new bolder and stronger messaging to demand attention and drive action to tackle the deadliest common cancer,” said Pancreatic Cancer UK.

“The TCS London Marathon is a key opportunity to raise vital income to fund research innovation while increasing public awareness, so that Pancreatic Cancer UK can reach more people with its award-winning support services.”

Next year’s event will be held on 27 April.

This year’s event raised a record £67m for good causes a day after it took place at the weekend. This tops London Marathon’s previous record for a one-day annual fundraiser.

---